Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 6,932,200 | 5,516,461 | 5,048,634 | 4,716,423 | 4,377,348 |
| Cost of Goods | 857,700 | 545,494 | 466,780 | 400,262 | 382,104 |
| Gross Profit | 6,074,500 | 4,970,967 | 4,581,854 | 4,316,161 | 3,995,244 |
| Operating Expenses | 3,559,800 | 3,115,612 | 2,857,943 | 3,067,534 | 2,699,921 |
| Operating Income | 2,515,500 | 1,855,849 | 1,724,691 | 1,248,889 | 1,295,427 |
| Other Income | -52,100 | -5,262 | -13,477 | -18,983 | 37,252 |
| Pre-tax Income | 2,463,400 | 1,850,587 | 1,711,214 | 1,229,906 | 1,332,679 |
| Income Tax | 601,000 | 470,554 | 444,528 | 331,333 | 355,617 |
| Net Income Continuous | 1,862,400 | 1,380,033 | 1,266,686 | 898,573 | 977,062 |
| Minority Interests | N/A | N/A | 32,258 | -106,700 | 6,930 |
| Net Income | $1,862,300 | $1,380,033 | $1,234,428 | $1,005,273 | $970,132 |
| EPS Basic Total Ops | 7.86 | 5.80 | 5.09 | 3.98 | 3.37 |
| EPS Basic Continuous Ops | 7.86 | 5.80 | 5.23 | 3.56 | 3.40 |
| EPS Diluted Total Ops | 7.81 | 5.76 | 5.04 | 3.94 | 3.35 |
| EPS Diluted Continuous Ops | 7.82 | 5.76 | 5.17 | 3.53 | 3.38 |
| EBITDA(a) | $3,047,100 | $2,221,497 | $2,083,624 | $1,604,633 | $1,723,388 |